SLDB (SLDB) Stock Price & Analysis
SLDB (SLDB) fell 1.63% to USD 10.25 as of September 8, 2026 at 10:15 UTC, according to Nexqual real-time market data.
SLDB last closed at USD 10.25; the session ranged USD 10.2–10.48 on volume of 495,327 shares. Market capitalization is —, with a 52-week range of USD 3.79–11.45 (NMS). Source: Nexqual, September 8, 2026 at 10:15 UTC.
Key Statistics (as of September 8, 2026 at 10:15 UTC)
| Price | USD 10.25 |
|---|---|
| Change | ▼ 1.63% (down) |
| Previous Close | USD 10.25 |
| Open | USD 10.25 |
| Day Range | USD 10.2 – 10.48 |
| 52-Week Range | USD 3.79 – 11.45 |
| Volume | 495,327 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (SLDB)
Nexqual's technical model rates SLDB "BUY" based on 5 bullish and 1 bearish signals across 128 daily candles, as of September 8, 2026 at 10:15 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 62.03 (neutral) |
| vs SMA50 | Above (USD 9.3) |
| MACD | 0.38 (positive) |
From SLDB's Latest SEC 10-K Filing (filed 2026-03-19)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| VYGR | Voyager Therapeutics, Inc. | USD 3.51 | ▼ 0.85% |
| RGNX | REGENXBIO Inc. | USD 8.94 | ▼ 6.88% |
| MGTX | MeiraGTx Holdings plc | USD 13.89 | ▼ 1.21% |
| WVE | Wave Life Sciences, Inc. | USD 4.86 | ▼ 0.41% |
| STOK | Stoke Therapeutics, Inc. | USD 29.81 | ▼ 2.26% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 10:15 UTC. This page is informational and not investment advice.